Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.68 USD | +0.02% | -2.54% | +18.39% |
04-16 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
04-11 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.39% | 702M | |
+1.79% | 106B | |
+8.38% | 23.47B | |
-14.01% | 21.9B | |
-5.99% | 18.77B | |
-37.26% | 17.85B | |
-8.28% | 16.78B | |
+8.88% | 14.41B | |
+41.30% | 12.86B | |
+319.83% | 8.78B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- AnaptysBio Names John Orwin as Board Chairman